Modification of the Complement Binding Properties of Polystyrene: Effects of End‐Point Heparin Attachment
- 1 March 1993
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 37 (3) , 349-354
- https://doi.org/10.1111/j.1365-3083.1993.tb02564.x
Abstract
In recent years, conjugation of heparin to biomaterials has been shown to improve its biocompatibility. The purpose of the present work was to compare complement activation and binding of C3 to unmodified and heparin-treated polystyrene surfaces of microtitre plates. When polystyrene was incubated with human serum, C3 was deposited on the surface by both adsorption and binding dependent on activation of the classical (CPW) and alternative (APW) pathways After end-point attachment of heparin, significant C3 deposition, although at reduced levels, occurred only by CPW-mediated mechanisms. while adsorption and APW -mediated binding were strongly reduced. Generally, the modified surface bound lower amounts of protein, e.g. serum albumin and IgG, than the unmodified. By contrast, it had increased affinity for Clq which leads to binding of Cl and activation of complement via the CPW. Nevertheless, the net effect of the surface modification on the complement reaction was an overall reduction of C3 binding due to obliteration of APW. This can be related to an enhanced factor H/I-dependent down-regulation of C3b and to the lowered protein-adsorbing property of the surface, both of which have inhibitory effects on APW and on the C3 shunt-dependent activation of the complement system.Keywords
This publication has 29 references indexed in Scilit:
- Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surfaceMolecular Immunology, 1993
- Extracorporeal carbon dioxide removal performed with surface‐heparinized equipment in patients with ARDSActa Anaesthesiologica Scandinavica, 1991
- Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparinThe Annals of Thoracic Surgery, 1991
- The Search for Thromboresistance Using Immobilized HeparinAnnals of the New York Academy of Sciences, 1987
- Complement Activation in Extracorporeal CircuitsAnnals of the New York Academy of Sciences, 1987
- Treatment of Acute Respiratory Failure by Extracorporeal Carbon Dioxide Elimination Performed with a Surface Heparinized Artificial LungAnesthesiology, 1987
- Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragmentsMolecular Immunology, 1987
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Activation of C1, the first component of complement, the generation of C1r-C1s and C1̄ inactivator complexes in normal serum, by heparin-affinity chromatographyMolecular Immunology, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981